STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

This story was adapted from Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get ...

Candidates looking to enter biotech should focus on cultivating key skills, thoughtfully crafting their resumes and putting their best, most authentic foot forward in interviews. An internship, co-op ...

That's according to Dr Bianca Ogden, the jewel in Platinum Asset Management's biotech crown, who believes that we are now ...

Boston has become one of the top places for biotech research, and one of the big players in this space is CRISPR gene-editing ...

The biotech industry is a whirlwind of innovation, constantly pushing the boundaries of science to develop groundbreaking treatments and technologies. But navigating this complex landscape requires ...

Response Pharmaceuticals believes its experimental drug can lessen the persistent weight gain associated with antipsychotics.

Investing.com -- The outcome of the 2024 U.S. presidential election is poised to affect the biotechnology sector, as both major parties present policy proposals that could reshape drug pricing ...

The earnings season for the drug/biotech sector is now in its final lap, with some large biotech and generic drug companies due to report their third-quarter 2024 results this week. The remaining ...

Big amounts of selling in the healthcare-biotech sectors (NYSEARCA:XBI) could be signaling capitulation, followed by a rally, according to Piper Sandler. Capitulation is an extreme panic signal ...

There's several talking points that could impact CSL shares following the biotech's AGM. Management remains constructive on ...